« Back
Home /
N-Acetyl-Ser-Asp-Lys-Pro

N-Acetyl-Ser-Asp-Lys-Pro

Manufacturer	GenScript
Category	Oncology Neuroscience Aging & Neurological Disorders Infectious Diseases Viral Infections Coronavirus (COVID-19) Peptides & Proteins Cardiovascular Research Heart Failure Myocardial Infarction Peptides By Organ Bone Cancer
Type	Peptides
Specific against	other
Amount	5mg
Item no.	RP10555
Targets	ACE
eClass 6.1	34160400
eClass 9.0	32160409
Available
Description	Acetyl Ser-Asp-Lys-Pro is formed in bone marrow cells by enzymatic processing of thymosin beta4. It inhibits the entry of pluripotent hemopoietic stem cells into S-phase of the cell cycle and protects against Ara-C lethality in mice. Acetyl Ser-Asp-Lys-Pro is also a specific substrate for the N-terminal active site of angiotensin-converting enzyme, which is responsible for its degradation, in vivo .
Notes	(CFU-S = Spleen Colony-Forming Units) N-Acetyl-Ser-Asp-Lys-Pro exerts a high inhibitory activity on the proliferation of hematopoietic pluripotent stem cells
Storage	Store at -20C.
Product Origin	USA

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

RP10555-datasheet.pdf

RP10555-safety-datasheet.pdf